Skip to content
Back to AARD

Aardvark Therapeutics, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
4
Purchases
2
Sales
2
Purchase value
$144.60K
Sale value
$394.96K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Nelson SunSee Remarks
4Rule 10b5-1 plan disclosed
Filed Sep 11, 2026Period of report Sep 10, 20260001193125-26-389564
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 11, 2026
Common Stock, par value $0.00001 per shareF162,000$5.1803$321.18K35,475Direct
SaleSep 10, 2026
Common Stock, par value $0.00001 per shareF1F2F314,754$5.0006$73.78K97,475Direct
Filing footnotes · 3
  1. F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  2. F2The price reported in Column 4 reflects the weighted-average sales price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.0007, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3Includes 3,745 shares of common stock acquired pursuant to the Issuer's 2025 Employee Stock Purchase Plan on May 22, 2026.
Open on SEC EDGAR
Nelson SunChief Financial Officer
4
Filed Dec 12, 2025Period of report Dec 11, 20250001193125-25-318070
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseDec 11, 2025
Common Stock3,000$14.40$43.20K108,484Direct
Open on SEC EDGAR
Tien-Li LeeDirector · Chief Executive Officer · 10% owner
4
Filed Dec 12, 2025Period of report Dec 11, 20250001193125-25-318069
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseDec 11, 2025
Common Stock7,000$14.485$101.40K1,551,613Direct
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.